Transcatheter Tricuspid Valve Repair or Replacement
Transcatheter tricuspid edge-to-edge repair (T-TEER) with an FDA-approved device may be considered medically necessary for severe tricuspid regurgitation despite maximally tolerated guideline-directed medical therapy in individuals a heart team assesses as intermediate or high risk for open surgery. Transcatheter tricuspid valve replacement (TTVR) with an FDA-approved device may be considered medically necessary for severe tricuspid regurgitation despite maximally tolerated guideline-directed medical therapy in individuals a heart team identifies as TTVR candidates. T-TEER and TTVR are considered investigational in all other situations.